Modafinil as an adjunctive treatment to sleep deprivation in depression.
Sleep deprivation (SD) is a rapid-acting treatment for depression, but its clinical efficacy is hampered by high relapse rates after recovery sleep, and its effectiveness is reduced by the demanding effort needed for the patient to stay awake. To our knowledge, this is the first reported case of a successful treatment of depression with the combination of SD and the wakefulness-promoting agent modafinil. We suggest that modafinil may reinforce the action of SD, possibly by preventing daytime naps and microsleep, and may sustain the antidepressant effect of SD, possibly by stabilizing the resynchronization between the circadian clock and the sleep-wake cycle.
Even
Christian
C
Clinique des maladies mentales et de l'encéphale, Centre hospitalier Sainte-Anne, Université René Descartes, Paris, France. c.even@ch-sainte-anne.fr
Thuile
Jacques
J
Santos
Johana
J
Bourgin
Patrice
P
D000368:Aged; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000150:complications* / Q000523:psychology; D006801:Humans; D008297:Male; D000077408:Modafinil; D011569:Psychiatric Status Rating Scales; D012892:Sleep Deprivation
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000077408:Modafinil